Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Godavari Lifesciences Ltd
NSE: GODAVARILSBSE: 548248Pharma Formulations
₹883.50
▲ 4.70 (+0.53%)
Balance Sheet
- FY22: 2,815
- FY23: 3,109
- FY24: 3,475
- FY25: 3,942
- FY26: 4,444
- FY22: 0
- FY23: 0
- FY24: 119
- FY25: 0
- FY26: 0
- FY22: 3,612
- FY23: 3,887
- FY24: 4,796
- FY25: 5,831
- FY26: 6,199
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Share capital | 32 | 32 | 32 | 32 | 32 |
| Reserves | 2,784 | 3,077 | 3,444 | 3,910 | 4,412 |
| Total equity | 2,815 | 3,109 | 3,475 | 3,942 | 4,444 |
| Borrowings | 0 | 0 | 119 | 0 | 0 |
| Trade payables | 446 | 505 | 576 | 463 | 875 |
| Other current liabilities | 179 | 237 | 231 | 223 | 419 |
| Other liabilities | 172 | 36 | 394 | 1,204 | 462 |
| Total liabilities | 3,612 | 3,887 | 4,796 | 5,831 | 6,199 |
| Net block | 1,532 | 1,750 | 2,034 | 2,411 | 2,795 |
| Capital work in progress | 58 | 80 | 48 | 132 | 97 |
| Investments | 146 | 303 | 594 | 443 | 387 |
| Inventories | 711 | 550 | 803 | 1,060 | 790 |
| Trade receivables | 578 | 588 | 630 | 797 | 781 |
| Cash & equivalents | 318 | 431 | 544 | 766 | 715 |
| Other current assets | 270 | 185 | 144 | 222 | 633 |
| Total assets | 3,612 | 3,887 | 4,796 | 5,831 | 6,199 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium